Page last updated: 2024-08-24

cidofovir anhydrous and Infectious Skin Diseases

cidofovir anhydrous has been researched along with Infectious Skin Diseases in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	1 (33.33)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dagley, A; Downs, B; Hagloch, J; Smee, DF; Tarbet, EB	1
Blauvelt, A; Sanchez, S; Toro, JR; Turiansky, G	1
De Clercq, E; Holý, A	1

Reviews

1 review(s) available for cidofovir anhydrous and Infectious Skin Diseases

Article	Year
Topical cidofovir for the treatment of dermatologic conditions: verruca, condyloma, intraepithelial neoplasia, herpes simplex and its potential use in smallpox. Dermatologic clinics, 2003, Volume: 21, Issue:2 Topics: Administration, Cutaneous; Administration, Topical; Antiviral Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Cidofovir; Condylomata Acuminata; Cytosine; Herpes Simplex; Humans; Organophosphonates; Organophosphorus Compounds; Skin Diseases, Infectious; Skin Neoplasms; Smallpox; Warts	2003

Article

Year

Topical cidofovir for the treatment of dermatologic conditions: verruca, condyloma, intraepithelial neoplasia, herpes simplex and its potential use in smallpox.

Dermatologic clinics, 2003, Volume: 21, Issue:2

Topics: Administration, Cutaneous; Administration, Topical; Antiviral Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Cidofovir; Condylomata Acuminata; Cytosine; Herpes Simplex; Humans; Organophosphonates; Organophosphorus Compounds; Skin Diseases, Infectious; Skin Neoplasms; Smallpox; Warts

2003

Other Studies

2 other study(ies) available for cidofovir anhydrous and Infectious Skin Diseases

Article	Year
Enhanced efficacy of cidofovir combined with vaccinia immune globulin in treating progressive cutaneous vaccinia virus infections in immunosuppressed hairless mice. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:1 Topics: Administration, Topical; Animals; Antiviral Agents; Cidofovir; Cytosine; Disease Models, Animal; Drug Therapy, Combination; Female; Immunoglobulins; Infusions, Parenteral; Mice, Hairless; Mice, SCID; Organophosphonates; Skin Diseases, Infectious; Treatment Outcome; Vaccinia	2015
Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine in various models of herpes simplex virus infection in mice. Antimicrobial agents and chemotherapy, 1991, Volume: 35, Issue:4 Topics: Acyclovir; Animals; Antiviral Agents; Brain Diseases; Cidofovir; Cytosine; Herpes Simplex; Mice; Mice, Hairless; Mice, Nude; Organophosphonates; Organophosphorus Compounds; Peritoneal Cavity; Skin Diseases, Infectious	1991

Article

Year

Enhanced efficacy of cidofovir combined with vaccinia immune globulin in treating progressive cutaneous vaccinia virus infections in immunosuppressed hairless mice.

Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:1

Topics: Administration, Topical; Animals; Antiviral Agents; Cidofovir; Cytosine; Disease Models, Animal; Drug Therapy, Combination; Female; Immunoglobulins; Infusions, Parenteral; Mice, Hairless; Mice, SCID; Organophosphonates; Skin Diseases, Infectious; Treatment Outcome; Vaccinia

2015

Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine in various models of herpes simplex virus infection in mice.

Antimicrobial agents and chemotherapy, 1991, Volume: 35, Issue:4

Topics: Acyclovir; Animals; Antiviral Agents; Brain Diseases; Cidofovir; Cytosine; Herpes Simplex; Mice; Mice, Hairless; Mice, Nude; Organophosphonates; Organophosphorus Compounds; Peritoneal Cavity; Skin Diseases, Infectious

1991